Body reacted first to the Jin Matrix patent news

Picked up Jin Matrix today. The GM-CAD1 gene delivery platform US patent news pushed the price up right away.

Reacted to the patent news

The 90-point score made the move look solid. That score basically shows how likely the platform patent will turn into real sales. Saw the news and jumped in.

Left the holdings untouched. No add-on buys or sells, just watching. Portfolio now sits with only Jin Matrix riding short-term flow.